Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/2009
05/26/2009US7538086 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative disorders
05/26/2009US7538083 Compositions and methods for the potentiation of immune responses against target antigens
05/26/2009US7537929 Nucleotide sequences coding serine protease inhibitor for use in targeting and killing insect cell
05/26/2009US7537928 Expression vector comprising nucleotide sequences coding potassium chanel protein for use as tools in identifying modulator for prevention and treatment of cardiovascular/myocardial disorders
05/26/2009US7537914 Nucleic acid and allergenic polypeptides encoded thereby in cashew nuts (Anacardium occidentale)
05/26/2009US7537899 Defects in periaxin associated with myelinopathies
05/26/2009US7537896 Androgen-regulated PMEPA1 gene and polypeptides
05/26/2009US7537893 Mitochondrial ND5 gene mutations in Parkinson's disease
05/26/2009US7537891 Using glyceraldehyde-3-phosphate dehydrogenase expression as evaluative tool in identifying tumor antigen expression; diagnosing and prognosing cell proliferative disorders
05/26/2009US7537772 Chlamydia protein, gene sequence and the uses thereof
05/26/2009US7537771 Produces an immune response which is protective against Bacillus anthracis
05/26/2009US7537768 Influenza virus vaccine composition and methods of use
05/26/2009US7537760 Monoclonal antibodies recognizing BAG3 protein sequences and their use in diagnostic and therapy of cell death-involving diseases
05/26/2009US7537758 Antibodies against a peptide epitope of apolipoprotein B
05/26/2009US7537757 Administering an antibody that specifically binds to EMAP(endothelial monocyte-activating polypeptides II) to the subject which needs inhibition of EMAP activity in an amount effective to stimulate vascular growth in cardiac muscle
05/26/2009US7537755 Interferon-alpha polypeptides and conjugates
05/26/2009CA2497857C Novel p-selectin ligand protein
05/26/2009CA2450691C Genes and proteins involved in the biosynthesis of lipopeptides
05/26/2009CA2295936C Chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof
05/26/2009CA2295322C Methods and compositions for rapid purification of proteasomes and methods of use of components thereof
05/26/2009CA2284541C Detoxified mutants of bacterial adp-ribosylating toxins as parenteral adjuvants
05/26/2009CA2230492C Human growth hormone variants
05/26/2009CA2225903C Aromatic diselenides and selenosulfides, their preparation and their uses, more particularly their therapeutical use
05/26/2009CA2174325C Non-antigenic branched polymer conjugates
05/26/2009CA2141022C Allergen of cladosporium herbarum
05/26/2009CA2091102C Microsomal triglyceride transfer protein
05/22/2009WO2009064924A1 Compositions and methods for making androstenediones
05/22/2009WO2009064805A1 Compositions and methods for the therapy and diagnosis of influenza
05/22/2009WO2009064118A2 Polypeptide inducing dwarfism of plants, polynucleotide coding the polypeptide, and those use
05/22/2009WO2009063507A1 Dna vaccine against anthrax
05/22/2009WO2009063466A1 Compositions and methods for inhibiting hiv-1 replication and integrase activity
05/22/2009WO2009063459A2 Synthetic peptide copolymers for treatment of neurodevelopmental disorders
05/22/2009WO2009063312A2 Nucleic acid sequences encoding transcription factors regulating alkaloid biosynthesis and their use in modifying plant metabolism
05/22/2009WO2009063110A1 Method of identifying compounds that induce or inhibit endoplasmic reticulum stress or oxidative stress
05/22/2009WO2009063072A2 Pharmaceutical compositions comprising glp-1 peptides or exendin-4 and a basal insulin peptide
05/22/2009WO2009062898A1 New synthetic arginine substituted peptides and their use
05/22/2009WO2009062532A1 Live attenuated metapneumovirus strains and their use in vaccine formulations and chimeric metapneumovirus strains
05/22/2009WO2009062399A1 Peptide ligand directed drug delivery
05/22/2009WO2009062348A1 Methods for inhibiting influenza virus infection and their drugs
05/22/2009WO2009062241A1 Crystal structure of a bacterial enzyme and uses thereof
05/22/2009WO2009062238A1 Epitope for neutralizing antibodies
05/22/2009WO2009045377A3 A non-desensitizing mutant of the transient receptor potential trpm5 ion channel
05/22/2009WO2009042794A3 Venezuelan equine encephalitis replicons expressing paramyxovirus glycoproteins as vaccine
05/22/2009WO2009040543A3 Bioactive peptide
05/22/2009WO2009035929A3 Cardiovascular and brain cell therapy using intracellular ryanodine receptor modulation by the estrogen receptor beta
05/22/2009WO2009034134A3 Use of natriuretic peptides for treating angioedema syndromes
05/22/2009WO2009031095A3 Multi-block copolymers
05/22/2009WO2009028968A8 Cell marker of melanocyte cell lineage and uses thereof
05/22/2009WO2009024862A3 Process
05/22/2009WO2009024327A3 New proteins for use in human and animal staphylococcus infections
05/22/2009WO2009003977A3 Plants having enhanced yield-related traits and a method for making the same
05/22/2009WO2008152446A3 Novel glycosylated peptide target in neoplastic cells
05/22/2009WO2008140573A3 Methods for reversibly binding a biotin compound to a support
05/22/2009WO2008129180A3 Novel viii factors for the treatment of type a hemophilia
05/22/2009WO2008034133A3 Effect of tula on hiv
05/22/2009WO2007030244A3 An ultra-high yield intravenous immune globulin preparation
05/22/2009WO2006126188A3 Cxcr4 antagonists for wound healing and re-epithelialization
05/22/2009WO2006072954A3 Novel il-6 polynucleotides encoding variant il-6 polypeptides and methods using same
05/22/2009WO2003003984A9 Novel proteins and nucleic acids encoding same
05/22/2009WO2002057787A9 Detection of survivin in the biological fluids of cancer patients
05/22/2009CA2705923A1 Antibodies to lrp6
05/22/2009CA2705821A1 Pharmaceutical compositions containing insulin and an insulinotropic peptide
05/22/2009CA2705765A1 Method of efficient extraction of protein from cells
05/22/2009CA2705555A1 Compositions and methods for the therapy and diagnosis of influenza
05/22/2009CA2705289A1 Production of cytotoxic antibody-toxin fusion in eukaryotic algae
05/22/2009CA2703894A1 New synthetic arginine substituted peptides and their use
05/22/2009CA2688306A1 Nucleic acid sequences encoding transcription factors regulating alkaloid biosynthesis and their use in modifying plant metabolism
05/21/2009US20090133164 EG1117 polynucleotides and uses thereof
05/21/2009US20090133162 Method of increasing plant organ and seed size in a plant
05/21/2009US20090133161 ethylene sensitivity is decreased; transgenic plants; agronomics
05/21/2009US20090133160 Polyoleosins
05/21/2009US20090133156 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics and phenotypes
05/21/2009US20090133155 Modification of Flavonoid Biosynthesis in Plants
05/21/2009US20090133153 Polypeptide participating in pyridoxine biosynthesis, polynucleotide encoding the polypetide and those uses
05/21/2009US20090133135 Diagnostic and Therapeutic Target SLC39A11 Proteins for Neurodegenerative Diseases
05/21/2009US20090131646 Novel bag proteins and nucleic acid molecules encoding them
05/21/2009US20090131645 used to control the interaction of particular cell types with their external environment; for chronic pain; reduced side effects, long-lasting actions that do not require frequent injections or long-term catheterization; does not lead to tolerance and associated dependence
05/21/2009US20090131641 Method for assembling subunits into capsoids
05/21/2009US20090131637 Vanilloid receptor
05/21/2009US20090131634 Method for Preparing Cell Fraction Containing Hemangioblasts
05/21/2009US20090131524 Sialic acid abc transporters in prokaryotes therapeutic targets
05/21/2009US20090131350 Hybrid Hepatocyte Growth Factor Gene Having High Expression Efficiency of Two Heterotypes of Hepatocyte Growth Factor
05/21/2009US20090131319 Protein of given amino acid sequence; heterologous polypeptide comprises Fc portion of antibody molecule; identifying agonists and antagonists; diagnosis and treatment of disease resulting from aberrant cell proliferation
05/21/2009US20090131318 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
05/21/2009US20090131317 Compounds and peptides that bind the trail receptor
05/21/2009US20090131316 Glucagon-like peptide-1 secretagogue, glucagon-like peptide-1 secretagogue food or drink, inhibitor of postprandial rise in blood glucose, and inhibitory food or drink of postprandial rise in blood glucose
05/21/2009US20090131314 Thrombospondin-1 Derived Peptides and Treatment Methods
05/21/2009US20090131312 Non-natural chemokine receptor ligands and methods of use thereof
05/21/2009US20090131311 Method for Preventing Formation of Trisulfide Derivatives of Polypeptides
05/21/2009US20090131310 Mucin3 egf-like domains
05/21/2009US20090131308 Splice Variants of ErbB Ligands, Compositions and Uses Thereof
05/21/2009US20090131306 Chemically modified cyclic peptides containing cell adhesion recognition (car) sequences and uses therefor
05/21/2009US20090131264 Method for selecting stable proteins in non-standard physicochemical conditions
05/21/2009US20090130763 Method of Controlling Degradation of Protein by Tetracycline Antibiotic
05/21/2009US20090130762 Activation of HCV-specific T cells
05/21/2009US20090130758 insecticidal activity of the protein against Lepidopteran pests (moths); biological pesticides
05/21/2009US20090130727 Method of expressing long-chain prenyl diphosphate synthase
05/21/2009US20090130718 Gene site saturation mutagenesis
05/21/2009US20090130716 Rationally designed antibodies
05/21/2009US20090130711 Recombinant vector capable of increasing secretion of koji mold protease